v3.26.1
Nature of the Business - Liquidity (Details)
$ in Millions
12 Months Ended
Jul. 14, 2026
USD ($)
Jul. 14, 2025
shares
Dec. 31, 2025
USD ($)
Class of Stock [Line Items]      
Reverse stock split ratio   0.08 0.08
Reverse stock split shares | shares   0  
Cash, cash equivalents and marketable securities     $ 41.8
Avere Therapeutics, Inc. | Subsequent Event      
Class of Stock [Line Items]      
Aggregate purchase price $ 320.0